Last reviewed · How we verify
NCT07042893
Effects of Pulmonary Resection on Right Ventricular Function
trial in Pulmonary Resection in 25 participants. Currently enrolling.
31 August 2025
Quick facts
| Lead sponsor | Çağrı Özdemir |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 1 April 2025 |
| Primary completion | 31 August 2025 |
| Estimated completion | 15 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Pulmonary Resection — all drugs for Pulmonary Resection →
- Right Ventricular Function — all drugs for Right Ventricular Function →
- Echocardiography — all drugs for Echocardiography →
- Cardiothoracic Anesthesia — all drugs for Cardiothoracic Anesthesia →
Sponsor
Çağrı Özdemir
Who can join
Adults 18 to 80, any sex, with Pulmonary Resection or Right Ventricular Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lung resection is associated with high postoperative morbidity and mortality and leads to a significant long-term decrease in functional capacity, particularly due to cardiorespiratory complications. One of the contributing factors to this functional decline is the postoperative reduction in right ventricular function. Due to the anatomical proximity and interactions, right ventricular function is evaluated by echocardiography following lung resection. The pulmonary artery pressure (PAP)/tricuspid annular plane systolic excursion (TAPSE) ratio is a parameter that provides a more comprehensive assessment of right heart function by evaluating both right ventricular systolic function and pulmonary artery pressure. In this study, investigators aimed to evaluate changes in right heart function by performing preoperative and postoperative echocardiographic assessments in participants undergoing lung resection, focusing on PAP/TAPSE ratios.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07042893
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Çağrı Özdemir trials
Trials by the same sponsor.
- NCT07040735 — Low-Flow Anesthesia and Open-Heart Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07042893 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Çağrı Özdemir
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07042893.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing